// App-Quantinova.ai

: Lung perfusion in pulmonary hypertension – results from the RESPIRE study

Researchers

Presenter

  • Paul Hughes

Principal Investigators

  • Andrew Swift

  • Frederick Wilson

  • Marcella Cogliano

  • Faisal Alandejani

  • Anthony Cahn

  • Lindsay Kendall

  • David Kiely

  • Jim Wild

Medical Centers

  • Academic Unit of Nephrology, Department of Infection, Immunity and Cardiovascular disease University of Sheffield Sheffield United Kingdom

  • GlaxoSmithKline, Stevenage, United Kingdom.

  • University of Sheffield, Sheffield, United Kingdom

  • Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • Dynamic contrast-enhanced magnetic resonance imaging

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved